Get started
Author

Mishal Iqbal

ORCID: 0009-0006-9843-0157
Observed ORCID: 0009-0006-9843-0157
OpenAlex ID: A5091278392
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 362
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 142
A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant–associated bleeding
2025 · Richard J. Buka, Michala Pettitt, et al. · Journal of Thrombosis and Haemostasis · 9
PDF
Nickel bioaccumulation, physio-biochemical responses, phytotoxicity, and its mitigation strategies in plants
2026 · Mishal Iqbal, Asif Mukhtiar, et al. · Discover Plants. · 5
PDF
A technical review of in situ conversion technologies for oil shale
2026 · Atif Zafar, Mishal Iqbal, et al. · Petroleum Research · 5
A UK-wide analysis of the use of reversal agents in 198 patients on direct oral anticoagulants prior to urgent procedures
2026 · Molly Murphy, Michala Pettitt, et al. · Research and Practice in Thrombosis and Haemostasis · 1
Immunoinformatics-Guided Design and Molecular Dynamics Evaluation of a Multi-Epitope Vaccine Targeting High-Risk HPV-16 and HPV-18
2026 · Sadia Zahid, Sidra Saeed, et al. · Pakistan Journal of Medical & Cardiological Review
PDF
Ionic Microdomains as Emerging Determinants of Compensatory Nephron Hypertrophy: A Paradigm Shift in Renal Cellular Signaling
2026 · Karan Chaman Lal, Ayesha Ubaid Ullah‎, et al. · INNOVAPATH
PDF
Works count: 8
Citation count: 524
H-index: 5
I10-index: 2
Year
Topic
Type